Targeting C/EBPα overcomes primary resistance and improves the efficacy of FLT3 inhibitors in acute myeloid leukaemia
Used in this study: Immunodeficient B-NDG Mice
Read entire articleUsed in this study: Immunodeficient B-NDG Mice
Read entire article